收稿日期: 2020-05-15
网络出版日期: 2020-12-30
基金资助
山东省济宁医学院教师扶持基金(JY2017KJ008);山东省济宁医学院教师扶持基金(JY2017KJ008)
A pathway analysis of impact of chemotherapy-induced peripheral neuropathy and its predictors on quality of life among cancer patients
目的 基于不悦症理论构建化疗致周围神经病变及其影响因素对癌症患者生活质量影响的路径模型,为制订癌症患者化疗致周围神经病变及生活质量的干预措施提供科学依据。方法 2018年7月—2019年7月选取某三级甲等医院进行化疗的302例癌症患者为研究对象,采用患者健康状况问卷、领悟社会支持量表、化疗致周围神经病变评估工具及癌症治疗功能评价量表对癌症患者进行调查。结果 癌症分期（β=0.09,P=0.016）、抑郁（β=0.70,P<0.001）、社会支持（β=-0.11,P<0.001）对化疗致周围神经病变有直接效应;化疗致周围神经病变对生活质量有直接效应（β=-0.83,P<0.001）;癌症分期、抑郁及社会支持通过化疗致周围神经病变对生活质量有间接效应。结论 癌症分期、抑郁、社会支持是化疗致周围神经病变的影响因素,并对生活质量有间接效应,可为干预化疗致周围神经病变及提高患者生活质量提供理论依据。
任丽萍 , 王永芳 , 焦俊博 , 任梅 , 张传坤 , 高东芹 . 癌症患者化疗致周围神经病变及相关因素对生活质量的影响[J]. 中华护理教育, 2020 , 17(12) : 1129 -1133 . DOI: 10.3761/j.issn.1672-9234.2020.12.015
Objective To explore the impact of chemotherapy-induced peripheral neuropathy and its predictors on psychological well-being among cancer patients based on the Theory of Unpleasant Symptoms. Methods A cross-sectional survey was conducted with 302 cancer patients from one tertiary hospitals. Patients were assessed with questionnaires of Patient Health Questionnaire-9,Perceived Social Support Scale,Chemotherapy-induced Peripheral Neuropathy Assessment Tool,and Functional Assessment of Cancer Therapy-General from July 2018 to July 2019. Results Cancer stage（β=0.09,P=0.016）,depression（β=0.70,P<0.001）and social support（β=-0.11,P<0.001）had a direct effect on chemotherapy-induced peripheral neuropathy,and chemotherapy-induced peripheral neuropathy had a direct effect on quality of life（β=-0.83,P<0.001）. Cancer stage,depressionand social support had significant indirect effects on quality of life. Conclusion Cancer stage,depression and social support are the main factors affecting the chemotherapy-induced peripheral neuropathy,and these predictors have significant indirect impact on quality of life among cancer patients,which is of great significance for controlling the incidence of chemotherapy-induced peripheral neuropathy and improving the quality of life of cancer patients.
| [1] | Padmaja G, Vanlalhruaii C, Rana S, et al. Quality of life of pa-tients with cancer:a determinant of the quality of life of their family caregivers[J]. J Cancer Educ, 2017,32(3):655-661. |
| [2] | Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report:management of neuropathy in cancer[J]. J Natl Compr Canc Netw, 2009, 7(Suppl 5):S1-S26;quiz S27-8. |
| [3] | Argyriou AA, Bruna J, Anastopoulou GG, et al. Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity[J]. Support Care Cancer, 2020,28(4):1991-1995. |
| [4] | Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peri-pheral neuropathy:a current review[J]. Ann Neurol, 2017,81(6):772-781. |
| [5] | 洪悦颖, 徐晨, 于海燕, 等. 癌症患者化疗所致周围神经病变及影响因素分析[J]. 中华护理教育, 2019,16(12):892-896. |
| [6] | Yoon YJ, Park JS. Factors influencing peripheral neuropathy of cancer patients undergoing chemotherapy[J]. Asian Oncol Nurs, 2019,19(2):71-80. |
| [7] | Lenz ER, Pugh LC, Milligan RA, et al. The middle-range theory of unpleasant symptoms:an update[J]. ANS Adv Nurs Sci, 1997,19(3):14-27. |
| [8] | Smith MJ, Liehr PR. Middle range theory for nursing[M]. New York: Springer Publishing Company, 2013: 179. |
| [9] | Kline RB. Principles and practice of structural equation modeling[M]. New York: The Guilford Press, 2015: 16. |
| [10] | Kroenke K, Spitzer RL, Williams JB. The PHQ-9:validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613. |
| [11] | Wang WZ, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire(PHQ-9) in the general population[J]. Gen Hosp Psychiatry, 2014,36(5):539-544. |
| [12] | Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support[J]. J Pers Assess, 1988,52(1):30-41. |
| [13] | 姜乾金. 领悟社会支持量表[J]. 中国行为医学科学, 2001,10(10):41-43. |
| [14] | Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool[J]. Cancer Nurs, 2011,34(4):E10-E20. |
| [15] | Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale:development and validation of the general measure[J]. J Clin Oncol, 1993,11(3):570-579. |
| [16] | Cheung YB, Goh C, Wee J, et al. Measurement properties of the Chinese language version of the functional assessment of cancer therapy-general in a Singaporean population[J]. Ann Acad Med Singap, 2009,38(3):225-229. |
| [17] | 吴明隆. 结构方程模型:AMOS的操作与应用[M]. 重庆: 重庆大学出版社, 2009. |
| [18] | 顾芳红, 周建伟, 谢立芳. 清燥救肺汤加减对晚期非小细胞肺癌化疗患者生活质量和生存期的影响[J]. 中国实验方剂学杂志, 2020,26(11):142-147. |
| [19] | 夏为书. 宫颈癌患者同步放化疗期间的症状群与生活质量的相关性研究[D]. 南昌:南昌大学, 2019. |
| [20] | 唐磊, 强万敏, 王盈, 等. 癌症患者生活质量影响因素的研究现状[J]. 护士进修杂志, 2019,34(11):985-987. |
| [21] | 房宁宁, 付菊芳, 陈协群, 等. 白血病患者化疗期间的生活质量及其影响因素[J]. 解放军护理杂志, 2014,31(4):1-5. |
| [22] | Han SS, Han JW. The influences of depression,anxiety,social support and knowledge of anticancer drugs on the chemotherapy-induced peripheral neuropathy among colorectal cancer patients receiving oxaliplatin[J]. Journal of Korean Clinical Nursing Research, 2013,19(2):298-308. |
| [23] | Nielsen AM, Welch WA, Gavin KL, et al. Preferences for mHealth physical activity interventions during chemotherapy for breast cancer:a qualitative evaluation[J]. Support Care Cancer, 2020,28(4):1919-1928. |
| [24] | Kanda K, Fujimoto K, Kyota A. Emotional responses to persistent chemotherapy-induced peripheral neuropathy experienced by patients with colorectal cancer in Japan[J]. Asia Pac J Oncol Nurs, 2017,4(3):233-240. |
/
| 〈 |
|
〉 |